T1	Value 5 22	at least 18 years
T2	Person 0 4	Aged
R1	Has_value Arg1:T2 Arg2:T1	
T3	Condition 42 65	solid, malignant tumour
T4	Condition 77 85	lymphoma
T5	Negation 67 76	excluding
R2	Has_negation Arg1:T4 Arg2:T5	
T6	Qualifier 95 127	resistance to standard therapies
T7	Qualifier 131 168	for which no standard therapies exist
*	OR T7 T6
T8	Scope 95 168	resistance to standard therapies or for which no standard therapies exist
R3	Has_scope Arg1:T3 Arg2:T8	
R4	AND Arg1:T3 Arg2:T4	
T9	Multiplier 186 198	at least one
T10	Condition 199 205	lesion
T11	Qualifier 218 249	accurately assessed at baseline
T12	Procedure 253 281	Computerised Tomography (CT)
T13	Procedure 283 315	Magnetic Resonance Imaging (MRI)
T14	Procedure 319 330	plain X-ray
T15	Qualifier 338 370	suitable for repeated assessment
*	OR T14 T13 T12
R5	Has_qualifier Arg1:T10 Arg2:T11	
T16	Scope 253 330	Computerised Tomography (CT), Magnetic Resonance Imaging (MRI) or plain X-ray
R6	Has_scope Arg1:T11 Arg2:T16	
R7	Has_qualifier Arg1:T10 Arg2:T15	
R8	Has_multiplier Arg1:T10 Arg2:T9	
T17	Value 401 419	more than 12 weeks
T18	Observation 372 397	Estimated life expectancy
R9	Has_value Arg1:T18 Arg2:T17	
